Heterologous expression and purification of kynurenine-3-monooxygenase from Pseudomonas fluorescens strain 17400

Protein Expression and Purification

Volumn 51, Issue 2, 2007, Pages 324-333

  Crozier, Karen R ^a   Moran, Graham R ^a  

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

Aromatic; Expression; FAD; Flavin; Hydroxylase; Kynurenine; Monooxygenase; Oxygenase; Pseudomonas; Purification; Stroke

Indexed keywords

KYNURENINE 3 MONOOXYGENASE;

ARTICLE; ENZYME STABILITY; ENZYMOLOGY; ESCHERICHIA COLI; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR CLONING; PH; PSEUDOMONAS FLUORESCENS; SPECTROPHOTOMETRY;

CLONING, MOLECULAR; ENZYME STABILITY; ESCHERICHIA COLI; HYDROGEN-ION CONCENTRATION; KYNURENINE 3-MONOOXYGENASE; PSEUDOMONAS FLUORESCENS; SPECTROPHOTOMETRY;

BACTERIA (MICROORGANISMS); PSEUDOMONAS; PSEUDOMONAS FLUORESCENS;

EID: 33751406135     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2006.07.024     Document Type: Article

References (35)

1. Botting. Chemistry and neurochemistry of the kynurenine pathway of tryptophan metabolism. Chem. Soc. Rev. 24 (1995) 401-412
2. Carpenedo R., Pittaluga A., Cozzi A., Attucci S., Galli A., Raiteri M., and Moroni F. Presynaptic kynurenate-sensitive receptors inhibit glutamate release. Eur. J. Neurosci. 13 (2001) 2141-2147
3. Luthman J. The kynurenine pathway of tryptophan degradation as a target for neuroprotective therapies. Amino Acids 19 (2000) 273-274
4. Moroni F., Carpenedo R., Cozzi A., Meli E., Chiarugi A., and Pellegrini-Giampietro D.E. Studies on the neuroprotective action of kynurenine mono-oxygenase inhibitors in post-ischemic brain damage. Adv. Exp. Med. Biol. 527 (2003) 127-136
5. Malina H.Z., Richter C., Mehl M., and Hess O.M. Pathological apoptosis by xanthurenic acid, a tryptophan metabolite: activation of cell caspases but not cytoskeleton breakdown. BMC Physiol. 1 (2001) 7
6. 2+ increase in the presence of xanthurenic acid. BMC Ophthalmol. 2 (2002) 1
7. Okuda S., Nishiyama N., Saito H., and Katsuki H. Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine. Proc. Natl. Acad. Sci. USA 93 (1996) 12553-12558
8. Lipton S.A. Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults. NeuroRx 1 (2004) 101-110
9. Moroni F., Carpenedo R., and Chiarugi A. Kynurenine hydroxylase and kynureninase inhibitors as tools to study the role of kynurenine metabolites in the central nervous system. Adv. Exp. Med. Biol. 398 (1996) 203-210
10. Cozzi A., Carpenedo R., and Moroni F. Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia. J. Cereb. Blood Flow Metab. 19 (1999) 771-777
11. Nishimoto Y., Takeuchi F., and Shibata Y. Purification of l-Kynurenine 3-hydroxylase by affinity chromatography. J. Chromatogr. 169 (1979) 357-364
12. Uemura T., and Hirai K. l-Kynurenine 3-monooxygenase from mitochondrial outer membrane of pig liver: purification, some properties, and monoclonal antibodies directed to the enzyme. J. Biochem. (Tokyo) 123 (1998) 253-262
13. Uemura T., and Hirai K. Purification of l-Kynurenine 3-monooxygenase from pig liver mitochondrial outer membrane. Adv. Exp. Med. Biol. 398 (1996) 527-530
14. Uemura T., and Hirai K. Kynurenine 3-monooxygenase activity of rat brain mitochondria determined by high performance liquid chromatography with electrochemical detection. Adv. Exp. Med. Biol. 294 (1991) 531-534
15. Breton J., Avanzi N., Magagnin S., Covini N., Magistrelli G., Cozzi L., and Isacchi A. Functional characterization and mechanism of action of recombinant human kynurenine 3-hydroxylase. Eur. J. Biochem. 267 (2000) 1092-1099
16. Kurnasov O., Goral V., Colabroy K., Gerdes S., Anantha S., Osterman A., and Begley T.P. NAD biosynthesis: identification of the tryptophan to quinolinate pathway in bacteria. Chem. Biol. 10 (2003) 1195-1204
17. Entsch B., and Sim R.G. The purification and identification of flavin nucleotides by high-performance liquid chromatography. Anal. Biochem. 133 (1983) 401-408
18. Johnson-Winters K., Purpero V.M., Kavana M., and Moran G.R. Accumulation of multiple intermediates in the catalytic cycle of (4-hydroxyphenyl)pyruvate dioxygenase from Streptomyces avermitilis. Biochemistry 44 (2005) 7189-7199
19. Saito K., Quearry B.J., Saito M., Nowak Jr. T.S., Markey S.P., and Heyes M.P. Kynurenine 3-hydroxylase in brain: species activity differences and effect of gerbil cerebral ischemia. Arch. Biochem. Biophys. 307 (1993) 104-109
20. Alberati-Giani D., Cesura A.M., Broger C., Warren W.D., Rover S., and Malherbe P. Cloning and functional expression of human kynurenine 3-monooxygenase. FEBS Lett. 410 (1997) 407-412
21. Wiseman J.S., and Nichols J.S. A radiometric kynurenine monooxygenase assay. Anal. Biochem. 184 (1990) 55-58
22. Shin M., Sano K., and Umezawa C. Inhibition of l-Kynurenine 3-hydroxylase from Saccharomyces carlsbergensis by alpha-keto acid derivatives of branched chain amino acids. J. Nutr. Sci. Vitaminol. (Tokyo) 28 (1982) 191-201
23. Taylor M.G., and Massey V. Decay of the 4a-hydroxy-FAD intermediate of phenol hydroxylase. J. Biol. Chem. 265 (1990) 13687-13694
24. Entsch B., Ballou D.P., and Massey V. Flavin-oxygen derivatives involved in hydroxylation by p-hydroxybenzoate hydroxylase. J. Biol. Chem. 251 (1976) 2550-2563
25. Giordani A., Corti L., Cini M., Bormetti R., Marconi M., Veneroni O., Speciale C., and Varasi M. Enantiospecific synthesis and in vitro activity of selective inhibitors of rat brain kynureninase and kynurenine-3-hydroxylase. Adv. Exp. Med. Biol. 398 (1996) 531-534
26. Giordani A., Pevarello P., Cini M., Bormetti R., Greco F., Toma S., Speciale C., and Varasi M. 4-Phenyl-4-oxo-butanoic acid derivatives inhibitors of kynurenine 3-hydroxylase. Bioorg. Med. Chem. Lett. 8 (1998) 2907-2912
27. Heart Disease and Stroke Statistics 2005, The American Stroke Association.
28. Carpenedo R., Chiarugi A., Russi P., Lombardi G., Carla V., Pellicciari R., Mattoli L., and Moroni F. Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities. Neuroscience 61 (1994) 237-243
29. Carpenedo R., Meli E., Peruginelli F., Pellegrini-Giampietro D.E., and Moroni F. Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures. J. Neurochem. 82 (2002) 1465-1471
30. Guidetti P., Reddy P.H., Tagle D.A., and Schwarcz R. Early kynurenergic impairment in Huntington's disease and in a transgenic animal model. Neurosci. Lett. 283 (2000) 233-235
31. Colabroy K.L., and Begley T.P. The pyridine ring of NAD is formed by a nonenzymatic pericyclic reaction. J. Am. Chem. Soc. 127 (2005) 840-841
32. D.P. Ballou, in: Flavins and Flavoproteins, 1984, pp. 605-618.
33. Entsch B., Ballou D.P., and Massey V. Flavin-oxygen derivatives involved in hydroxylation by p-hydroxybenzoate hydroxylase. J. Biol. Chem. 251 (1976) 2550-2563
34. B. Entsch, D.P. Ballou, V. Massey, in: Flavins and Flavoproteins (18/0/15, B., Ed.), Elsevier, Amsterdam, 1976, pp. 111-123.
35. Maeda-Yorita K., and Massey V. On the reaction mechanism of phenol hydroxylase. New information obtained by correlation of fluorescence and absorbance stopped flow studies. J. Biol. Chem. 268 (1993) 4134-4144